0000930413-19-000024.txt : 20190104 0000930413-19-000024.hdr.sgml : 20190104 20190104170225 ACCESSION NUMBER: 0000930413-19-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190103 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Brien James Michael CENTRAL INDEX KEY: 0001632111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 19510922 MAIL ADDRESS: STREET 1: C/O ENZO BIOCHEM INC. STREET 2: 527 MADISON AVE. CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2019-01-03 0 0000316253 ENZO BIOCHEM INC ENZ 0001632111 O'Brien James Michael C/O ENZO BIOCHEM INC. 527 MADISON AVE. NEW YORK NY 10022 0 1 0 0 EVP of Finance Stock Option (to acquire common stock) 2.80 2019-01-03 4 A 0 52000 0 A 2020-01-04 2024-01-02 Common Stock 52000 33666 D The Reporting Person was granted 52,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning January 4, 2020. Does not include 10,500 Restricted Stock Units granted to the Reporting Person on January 3, 2019, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on January 3, 2022, and (ii) the continued service of the Reporting Person through January 3, 2022. /s/ James Michael O'Brien 2019-01-04